PMH40 COST-EFFECTIVENESS OF RITALINTM VERSUS ADDERALLTM FOR FIRST-LINE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN

May 1, 2004, 00:00
10.1016/S1098-3015(10)62235-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)62235-8/fulltext
Title : PMH40 COST-EFFECTIVENESS OF RITALINTM VERSUS ADDERALLTM FOR FIRST-LINE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62235-8&doi=10.1016/S1098-3015(10)62235-8
First page :
Section Title :
Open access? : No
Section Order : 173
Categories :
Tags :
Regions :
ViH Article Tags :